40 Participants Needed

Sentence Recast for Language Developmental Disorders

Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for emergent Spanish-English bilingual children with DLD. This project will examine the relationship between language proficiency and the language of intervention, considering monolingual intervention (Spanish or English) and interleaved Spanish-English intervention with the goal of improving language outcomes and thereby strengthening long-term academic achievement

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Sentence Recast for language developmental disorders?

Research shows that conversational recast treatment helps children with language disorders learn grammar more quickly and effectively compared to other methods. Children who frequently repeat correct forms during treatment tend to show better progress, indicating that this approach can be beneficial for improving language skills.12345

Is Sentence Recast therapy safe for humans?

The research articles reviewed do not provide specific safety data for Sentence Recast therapy, but they focus on its effectiveness in improving language skills in children with developmental language disorders. Generally, language interventions like Sentence Recast are considered safe as they involve structured language practice rather than medical or drug-based treatments.45678

How does the Sentence Recast treatment differ from other treatments for language developmental disorders?

Sentence Recast treatment is unique because it uses conversational recasting, where children repeat and correct sentences modeled by a clinician, helping them improve their language skills through practice and self-correction. This approach is different from other treatments as it focuses on spontaneous repetition and structural priming to enhance language development.24789

Eligibility Criteria

This trial is for emergent Spanish-English bilingual children in the USA with Developmental Language Disorder (DLD). It aims to help speech language pathologists decide on the best language of intervention. Specific eligibility criteria are not provided, but typically would include a diagnosis of DLD and being bilingual.

Inclusion Criteria

Pass a hearing screening test
Parent concerns and/or a history of receiving services in the public schools
Nonverbal IQ, as measured by the Kaufman Brief Intelligence Test-2, matrices subtest, will be at or above a standard score of 70.
See 3 more

Exclusion Criteria

My child does not have major sensory-motor or psychiatric issues.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive monolingual or interleaved therapy for 16 hours over 9 weeks, focusing on recast therapy in the dominant language with opportunities to use the non-dominant language.

9 weeks
Weekly sessions

Follow-up

Participants are monitored for language proficiency and effectiveness of the intervention after treatment.

4 weeks

Treatment Details

Interventions

  • Sentence Recast
Trial Overview The study is testing whether monolingual intervention (either in Spanish or English) or an interleaved approach combining both languages can better improve language outcomes for children with DLD. The goal is to enhance academic achievement over time.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Monolingual therapyExperimental Treatment1 Intervention
A trained, bilingual SLP will treat the targeted structure at a rate of \~ 1 recast per minute, for 16 hours spread over 9 weeks to obtain a planned dose of 912-1008 recasts (960 +/- 5%). Following evidence on enhanced conversational recasting, the SLP will obtain the child's attention before recasting and systematically vary the lexical items in the recasts. Children receiving monolingual Spanish therapy will have the entire treatment session conducted in the dominant language of the child (Spanish or English).
Group II: Interleaved therapyExperimental Treatment1 Intervention
A trained, bilingual SLP will treat the targeted structure at a rate of \~ 1 recast per minute, for 16 hours spread over 9 weeks to obtain a planned dose of 912-1008 recasts (960 +/- 5%). Following evidence on enhanced conversational recasting, the SLP will obtain the child's attention before recasting and systematically vary the lexical items in the recasts. Children will receive therapy in the dominant language (Spanish or English) and will also be offered the opportunity to use the non-dominant language (Spanish or English) via communication bid in the child's non-dominant language every 3-5 minutes and continue in that language as long as the child responds. If the child does not respond or responds in their dominant language, the examiner will switch to the other language.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Houston

Lead Sponsor

Trials
155
Recruited
48,600+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

University of Delaware

Collaborator

Trials
167
Recruited
25,700+

Findings from Research

Children with developmental language disorder who take longer than 10 days to correctly answer treatment items are unlikely to benefit from Enhanced Conversational Recast therapy, indicating a need for timely assessment of treatment effectiveness.
The study found that generalization of language skills after treatment is closely linked to accuracy achieved during treatment, but achieving less than 100% accuracy during therapy does not guarantee future generalization, suggesting that clinicians should aim for consistent high accuracy before concluding treatment.
Data-Informed Guideposts for Decision Making in Enhanced Conversational Recast Treatment.Hall, J., Plante, E.[2022]
Enhanced conversational recast treatment effectively improved the correct usage of targeted morphemes in preschoolers with developmental language disorder, regardless of whether they received treatment individually or in a small group setting (n = 20).
However, children in the group condition did not show significant improvement in using their partner's target morpheme, suggesting that simply hearing the target modeled is not enough for learning; active engagement with the recast is crucial for effective treatment.
Individual Versus Small Group Treatment of Morphological Errors for Children With Developmental Language Disorder.Eidsvåg, SS., Plante, E., Oglivie, T., et al.[2023]
Conversational recast treatment was found to be more effective than imitative treatment for helping both children with specific language impairment (SLI) and those with normal language skills acquire new language targets more quickly.
Children with SLI can learn grammatical structures as efficiently as their language-normal peers when given tailored language input that matches their developmental levels, suggesting that effective treatment strategies can bridge the gap in language acquisition.
Effects of imitative and conversational recasting treatment on the acquisition of grammar in children with specific language impairment and younger language-normal children.Nelson, KE., Camarata, SM., Welsh, J., et al.[2019]

References

Data-Informed Guideposts for Decision Making in Enhanced Conversational Recast Treatment. [2022]
Individual Versus Small Group Treatment of Morphological Errors for Children With Developmental Language Disorder. [2023]
Effects of imitative and conversational recasting treatment on the acquisition of grammar in children with specific language impairment and younger language-normal children. [2019]
The Role of Spontaneous Repetitions During Treatment of Morphosyntactic Forms for Children With Developmental Language Disorder. [2023]
Comparison of conversational-recasting and imitative procedures for training grammatical structures in children with specific language impairment. [2019]
Predictors of Treatment Response for Preschool Children With Developmental Language Disorder. [2023]
The efficacy of recasts in language intervention: a systematic review and meta-analysis. [2022]
Simultaneous treatment of grammatical and speech-comprehensibility deficits in children with Down syndrome. [2022]
The Use of Structural Priming and Focused Recasts to Facilitate the Production of Subject- and Object-Focused Relative Clauses by School-Age Children With and Without Developmental Language Disorder. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security